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Genome-wide associationIt has recently been hypothesized that polygenic adaptation, resulting in modest allele frequency changes at
many loci, could be a major mechanism behind the adaptation of complex phenotypes in human populations.
Here we leverage the large number of variants that have been identiﬁed through genome-wide association
(GWA) studies to comprehensively study signatures of natural selection on genetic variants associatedwith com-
plex traits. Using population differentiation basedmethods, such as FST and phylogenetic branch length analyses,
we systematically examined nearly 1300 SNPs associated with 38 complex phenotypes. Instead of detecting se-
lection signatures at individual variants, we aimed to identify combined evidence of natural selection by aggre-
gating signals across many trait associated SNPs. Our results have revealed some general features of polygenic
selection on complex traits associated variants. First, natural selection acting on standing variants associated
with complex traits is a common phenomenon. Second, characteristics of selection for different polygenic traits
vary both temporarily and geographically. Third, some studied traits (e.g. height and urate level) could have been
the primary targets of selection, as indicated by the signiﬁcant correlation between the effect sizes and the esti-
mated strength of selection in the trait associated variants; however, for most traits, the allele frequency changes
in trait associated variants might have been driven by the selection on other correlated phenotypes. Fourth, the
changes in allele frequencies as a result of selection can be highly stochastic, such that, polygenic adaptationmay
accelerate differentiation in allele frequencies among populations, but generally does not produce predictable di-
rectional changes. Fifth, multiple mechanisms (pleiotropy, hitchhiking, etc) may act together to govern the
changes in allele frequencies of genetic variants associated with complex traits.erms of t
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credited
, Cincinn
1 513 6
lished by© 2013 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).1. Introduction
Natural selection is the driving force behind adaptive evolution
(Barton, 2007). A comprehensive understanding of how natural selec-
tion affects human phenotypes could lead to insights into the evolution-
ary history and genetic architecture of such traits (Bamshad and
Wooding, 2003; Biswas and Akey, 2006; Fu and Akey, 2013; Nielsen
et al., 2007). Genes or genomic regions targeted by selection are typical-
ly functionally important and therefore identifying the regions under
selection can provide important mechanistic information about how
the polymorphism leads to phenotypic variation (Bamshad and
Wooding, 2003; Biswas and Akey, 2006; Nielsen et al., 2007).he Creative Commons
, and reproduction in
.
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Elsevier B.V. This is an openMany statistical tests have been developed to detect genetic signa-
tures of selection acting through different evolutionary mechanisms
and timescales (Oleksyk et al., 2010; Sabeti et al., 2006). These tests
have been used to identify some genomic loci that harbor common al-
leles that underlie human adaptive traits (Fu and Akey, 2013;
Grossman et al., 2013). Examples include DARC (Hamblin et al., 2002)
in malaria resistance, LCT (Bersaglieri et al., 2004; Poulter et al., 2003)
in lactose tolerance, SLC24A5 (Lamason et al., 2005) in skin pigmentation,
EPAS1 (Yi et al., 2010) in high-altitude tolerance, and EDAR in adaptation
to humid environment (Kamberov et al., 2013; Sabeti et al., 2007). Most
of the above examples emphasize classic selective sweeps in which a
new, strongly advantageous mutations increase rapidly in frequency,
even to ﬁxation, in the population. Strong positive selection for new var-
iants can result in selective sweeps (Akey, 2009; Fu and Akey, 2013) that
reduce the heterozygosity of nearby neutral polymorphisms and pro-
duces a strong genetic signature (i.e. a long haplotype with high
frequency)(Sabeti et al., 2006), a process referred to as genetic hitch-
hiking effect (Kaplan et al., 1989; Smith and Haigh, 1974). However, in-
creasing empirical and theoretical studies (Hancock et al., 2010;access article under the CC BY license
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2005) have suggested a role for “soft sweeps”, particularly adaptation by
modest changes in allele frequencies at many standing variants — so
called “polygenic adaptation”, could be the major mechanism behind
most adaptive events in natural populations (Pritchard and Di Rienzo,
2010; Pritchard et al., 2010). Unlike strong selective sweep, polygenic ad-
aptation depends on allele frequency changes atmany loci and the selec-
tion signature at any one locus is generally weak and can therefore be
difﬁcult to detect by conventional methods (Hancock et al., 2010;
Hermisson and Pennings, 2005; Przeworski et al., 2005).
Although being an old concept in classical quantitative genetics, poly-
genic adaptation has been largely neglected in human population genet-
ics studies (Pritchard and Di Rienzo, 2010), probably due to our
incomplete knowledge about the genetic architecture of complex
human traits and the difﬁculties in detecting the weak selection signals
at individual loci. Recently, genome-wide association (GWA) studies
have revealed thousands of genetic variants associated with hundreds
of complex human traits or diseases (http://www.genome.gov/
gwastudies/) (Hindorff et al., 2009). The results from GWA studies not
only conﬁrmed the highly polygenic nature of most complex human
traits (McCarthy et al., 2008; Stranger et al., 2011) but also enabled ag-
gregating signals of selection across multiple trait associated variants,
each of which might not stand out above the neutral background
(Pritchard et al., 2010). For examples, Amato et al. (2011) found the
mean FST of the 180 variants associated with human height to be signif-
icantly higher than the genomic background; Turchin et al. (2012) iden-
tiﬁed systematic allele frequency differences of height SNPs between
Northern and Southern Europeans; Casto and Feldman (2011) demon-
strated widespread selection on complex human traits through exami-
nation over 1300 GWAS SNPs; and Raj et al. (2013) observed
signiﬁcant enrichment of recent positive selection signatures among
more than 500 inﬂammatory-disease susceptibility SNPs. However,
there were also contradictory reports (Adeyemo and Rotimi, 2010;
Ding and Kullo, 2011; Lohmueller et al., 2006; Myles et al., 2008) that
did not detect unusually more differentiation of diseases associated var-
iants between populations, which might suggest that positive selection
does not have a strong effect on risk alleles in general.
In this study, we systematically examined nearly 1300 GWA SNPs
associated with 38 complex phenotypes, ranging from quantitative
physical or physiological traits to complex diseases. Instead of detecting
selection signature at individual variants, we aimed to identify com-
bined evidence of natural selection by aggregating signals across many
GWA SNPs associated with a particular trait. Speciﬁcally, for a complex
trait, we testedwhether the GWA SNPs collectively showed accelerated
differentiation among populations and tried to partition the observed
differentiation into speciﬁc human lineage(s). To explore the potential
ﬁtness effect of the polygenic traits, we assessed the correlation be-
tween the effect sizes of the trait associated SNPs and the estimated
strength of selection.We also investigatedwhether there is a signiﬁcant
trend in allele frequency changes that might favor directional shift in
trait values or disease risks.
Our results demonstrate that, GWA SNPs of many complex traits are
collectivelymore differentiated (in terms of allele frequencies) than the
genome-wide average, supporting the conclusion that natural selection
on variants associated with complex traits is a common phenomenon.
In some traits, the accelerated changes in allele frequencies of GWA
SNPsweremapped to speciﬁc human lineages, indicating that the selec-
tion forces on different polygenic traits vary both temporarily and geo-
graphically. In some traitswith strong evidence of natural selection (e.g.
height and urate level),we found signiﬁcant correlation between the ef-
fect sizes and the estimated strength of selection in the trait associated
SNPs, which might imply these traits could have been the primary tar-
gets of selection. But formost other traits, the accelerated allele frequen-
cy changes in trait associated SNPs might have been driven by the
selection on other correlated phenotypes. Furthermore, we did not ob-
serve signiﬁcant evidence of directional changes in allele frequenciesamong most of the traits examined in this study, which indicate poly-
genic selection might accelerate differentiation between populations
without producing predictable directional changes in allele frequencies.
Based on the inspection of individual SNPs showing signiﬁcant signals of
selection, we also found that multiple mechanisms (pleiotropy,
hitchhiking, etc.) may act together to govern the changes in allele fre-
quencies of complex trait associated SNPs.
2. Methods
2.1. Extraction of GWA SNPs of complex traits
We extracted GWA SNPs that are implicated in inﬂuencing complex
human traits or diseases from the National Human Genome Research
Institute (NHGRI) GWA catalog (http://www.genome.gov/gwastudies/).
For a speciﬁc trait, we included autosomal GWA SNPs with p-value
less than 5 × 10−8 reported in studies with sample size larger than
1000. Since different studies might report different leading SNPs to
index a signiﬁcant locus, we selected the most signiﬁcant one (with
smallest reported p-value) from multiple reported GWA SNPs if
they are physically adjacent to each other (b250 kb). Our analyses
of selection signatures (described below) required genotype data
from the 1000 Genomes Project and ancestral state of the variants.
Therefore, SNPs not presented in 1000 Genomes or whose ancestral
allele cannot be determined were excluded. When possible, we also
extracted the risk allele and the effect size estimates (beta or OR)
of the GWA SNPs from the single study with the largest number of
samples and reported signiﬁcant SNPs.
2.2. 1000 Genomes data
Genotype data from the 1000 Genomes Project (version 3 of the
phase 1 integrated variant call set based on both low coverage and
exome whole genome sequence data) were downloaded from ftp://
ftp.1000genomes.ebi.ac.uk/vol1/ftp/release/20110521/. Of the 14 sam-
pled 1000 Genomes populations, data from nine populations were
used, including four European (EUR) populations (CEU, GBR, TSI, FIN),
three East Asian (ASN) populations (CHB, CHS and JPT), and two
African (AFR) populations (YRI and LWK). The CLM, MXL, PUR and IBS
samples were excluded due to either high levels of admixture (CLM,
MXL and PUR) or small sample size (IBS, N = 14). The ancestral alleles,
constructed based on the 4-way EPO alignments (Paten et al., 2008a,
2008b) of human, chimp, orangutan and rhesus macaque sequences
were extracted from the INFO section of the 1000 Genomes VCF ﬁles.
2.3. FST analysis
Unbiased estimates of FST were calculated according to Weir and
Cockerham (1984). For each SNP under consideration, we calculated a
global FST as well as all pairwise FST between the nine 1000 Genomes
populations. We took the averages of selected pairwise FST to reﬂect
the genetic distances between or within major continental populations.
For examples: 1) the FST between African and Asian populations (AFR
and ASN) was calculated by arithmetic mean of FST (YRI_CHB), FST
(YRI_CHS), FST (YRI_JPT), FST (LWK_CHB), FST (LWK_CHS) and FST
(LWK_JPT); 2) the FST within European population (EUR) was calculat-
ed by arithmetic mean of FST (CEU_GBR), FST (CEU_TSI), FST (CEU_FIN),
FST (GBR_TSI), FST (GBR_FIN) and FST (TSI_FIN). The Weir and
Cockerham estimation of FST can yield negative values, although do
not have biological meaning, were kept to maintain the unbiased prop-
erty of the estimator.
2.4. Branch length analysis
To examine whether there are identiﬁable signiﬁcant selection sig-
nals along speciﬁc human lineages, we estimated the branch lengths
Fig. 1. (A) Population tree (topology) of the nine 1000 Genomes populations. (B) schematic graph of branch length estimation.
Table 1
Different measures of differentiation in allele frequencies among populations.
Measure Description
FST
Global Global FST calculated from 9 populations
AFR_ASN Average FST between major continental populations
AFR_EUR
ASN_EUR
AFR Average FST within continental populations
ASN
EUR
Branch length
Total Sum of all branch lengths
AFR Major split to African populations
EUA Major split to Eurasia
ASN Asia split from Eurasia
EUR European split from Eurasia
AFRs Average branch length of Afrian populations
ASNs Average branch length of Asian populations
EURs Average branch length of European populations
80 G. Zhang et al. / Applied & Translational Genomics 2 (2013) 78–94for the population tree of the nine studied populations (Fig. 1A). We
ﬁrst constructed the tree topology using the neighbor joining (NJ)
method (Saitou and Nei, 1987) based on average pairwise FST esti-
mated from 10,000 randomly selected 1000 Genomes SNPs. This to-
pology was consistent with the one based on classic blood group and
protein loci (Nei and Roychoudhury, 1993). Given this ﬁxed topolo-
gy, two methods were used to estimate the branch lengths based
on the allele frequencies of each SNP: 1) the Ordinary Least Squares
(OLS) method (Chakraborty, 1977; Rzhetsky and Nei, 1992); and 2)
a maximum likelihood (ML) method based on the diffusion approx-
imation (Kimura, 1962) of allele frequency changes. Speciﬁcally, the
ﬁrst method (OLS) estimates branch lengths by minimizing the
squared errors between the observed genetic distances (i.e. pairwise
FST between leaf nodes) and the distances over the tree (i.e. the sum
of the branch lengths in the path between two leaf nodes). The sec-
ond method (ML) was motivated by a hierarchical model of allele
frequency changes among related populations (Nicholson et al.,
2002), which assumes descendent populations diverge and evolve
independently from an ancestral population (parental node) and
the allele frequency in a descendent population is approximated by
a normal distribution. As shown by a simple example (Fig. 1B), the
allele frequency of PopB can be written as pB ∼ N[pA, cBpA(1 − pA)],
where pA is the allele frequency in the ancestral population (PopA)
and cB is the branch length parameter relevant to the demographic
history of PopB. Under pure drift setting, cB ¼∑
tB
i¼1
1
2Ni
, where tB is the
number of generations since PopB split from PopA andNi is the effective
population size of each generation. Conditional on the ancestral allele
frequencies, the same model applies, independently, to all the non-
root populations in a tree. Thus, the full likelihood of a population tree
can be written as the product of the likelihoods of every non-root
nodes:
L ¼ ∏
i
N pi ; cipi 1−pið Þ
 
where i denotes each (non-root) population, pi is the allele frequency of
the population and pi⁎ is the allele frequency in the immediate ancestral
population (parent node), and ci is the branch length. The branch lengths
(ci) and the allele frequencies in ancestral populations were then esti-
mated by numerical maximization of the likelihood function. A detailed
description of the method will be reported elsewhere. The branch
lengths estimated by these two methods are similar and both can be
interpreted as analogous to FST between a population and its hypotheti-
cal ancestor (parent node). To reduce the number of comparisons, wefocused on the major splits of continental populations (i.e. AFR, EUA
[Eurasia], ASN and EUR in Fig. 1A) and aggregated the terminal branches
to reﬂect the average of within continental splits (indicated by EURs,
ASNs and AFRs in Fig. 1A). The sum of branch lengths for the entire
tree was also calculated.
2.5. Statistical test
For a particular complex trait, we inferred the aforementioned FST
and the branch lengths (summarized in Table 1) from the allele fre-
quency data of individual GWA SNPs. A permutation procedure was
performed to test whether the inferred measures across all of the
GWA SNPs associated with a particular trait collectively implies signiﬁ-
cant signature of selection. 5000 permutation sets of SNPs were drawn
at random from the 1000 Genomes data and matched to the GWA
SNPs on a one-by-one basis by having similar ancestral allele frequency
in the European 1000 Genome samples. The distributions and mean
values of the estimated FST and the branch lengths obtained from the
GWA SNPs were then compared to the permutation sets to calculate
empirical p-values. Since we were interested in detecting signatures of
selection that lead to accelerated population differentiation, one-tailed
p-values for increased FST and branch lengthswere used. Similar empir-
ical p-valueswere also calculated for individual GWASNPs to reﬂect the
signiﬁcance of selection on individual GWA SNPs.
Multiple (38) complex traits and a large number (nearly 1300) of
GWA SNPs associated with these traits were examined in this study.
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testing, becausewe assume natural selection is a common phenomenon
and a multiple testing correction based on family-wise error rate (i.e.
Bonferroni correction) would be too stringent. Instead, we arbitrarily
set two levels (signiﬁcant p-value b 0.01 and marginally signiﬁcant p-
value b 0.05) to rank the signiﬁcance of evidence for selection.
2.6. Correlation between effect sizes and strength of selection
We also examined whether the strength of selection signatures are
correlated with the reported effect sizes of the GWA SNPs. In classical
quantitative genetics, strength of natural selection with respect to a ge-
notype (or a phenotype) is measured by ﬁtness (Falconer and Mackay,
1996). Differences in ﬁtness can be used to predict the allele frequency
change over generations. However, despite its core importance, it is al-
most impossible to measure small ﬁtness differences among genotypes
in natural populations (Orr, 2009). In this current study, we used esti-
mated FST (global) and branch length (total) as surrogates to reﬂect
the strength of directional selection. It can be shown that, when a direc-
tional selection with no dominance is assumed, the estimated FST and
branch length should have an approximately linear relationship with
the expected allele frequency change Δq = sq(1 − q)/2, where q is
the allele frequency before selection, s is the selection coefﬁcient, and
theﬁtness for each genotype AA, Aa and aa are 1, 1 − s/2, and 1 − s, re-
spectively. Following this logic we tested correlation between the esti-
mated strength of selection signatures (i.e. FST or branch length) and
the allele frequency adjusted effect sizes βq(1 − q), where β is the re-
ported beta values or log transformed ORs and q is the allele frequency
in European populations. The statistical signiﬁcance of the correlation
was accessed by both parametric (Pearson correlation) and non-
parametric (Kendall's tau) methods.
2.7. Tests for directional changes in allele frequencies
Suppose natural selection favors directional change (e.g. increasing)
in trait value of a complex phenotype (or risk to a complex disease) —
under this premise,we should anticipate observingmore derived alleles
that increase the trait value than derived alleles that decrease the trait
value and the frequencies of derived alleles with increasing effects
should be higher than the derived alleles with decreasing effects or
vice versa. Therefore, we grouped the reported GWA SNPs according
to the effect direction of the derived alleles (i.e. positive or negative)
and tested whether the counts and the derived allele frequencies of
the two groups of GWA SNPs are signiﬁcantly different as overall evi-
dence for directional selection. A two-tailed binomial test was conduct-
ed to compare the counts of derived alleles and a two-sampleWilcoxon
test was used to compare the frequency distributions of the derived al-
leles with positive or negative effects.
3. Results
3.1. Extraction of complex traits and GWA SNPs
We compiled a list of complex traits and their associated GWA SNPs
from the NHGRI GWA catalog (http://www.genome.gov/admin/
gwascatalog.txt, downloaded on May 13, 2013). This version of GWA
catalog includes 12,430 GWA records on 826 traits from 1770 published
studies. Since our study aimed at identifying collective selection signa-
tures on standing genetic variants of complex traits by aggregating evi-
dence frommultiple GWASNPs,we included 38 complex traits/diseases
with more than 15 index GWA SNPs that passed our selection criteria
(i.e. autosomalGWASNPswith p-value b 5 × 10−8). Because of the im-
plications for natural selection upon psychiatric disorders genes (Keller
and Miller, 2006), we included Schizophrenia and Bipolar disorder by
lowering the p-value b 5 × 10−6. The selected traits and the counts of
GWA SNPs were listed in Table 2. The 38 traits can be grossly groupedinto 7 categories: 1) quantitative physical traits (i.e. height, BMI and
blood pressures); 2) quantitative physiological traits; 3) inﬂammatory
or autoimmune disorders; 4) common complex disorders; 5) mental
disorders 6) cancers; and 7) a miscellaneous category related to men-
struation. In total, 1458 signiﬁcant GWA associations of 1296 distinct
SNPs (a SNP could associatewithmultiple traits)were extracted, and ef-
fect size information was available for 1082 GWA SNP associations.
In the following, we ﬁrst detail our results from height GWA SNPs to
illustrate the logical organization of our multifaceted analyses. The re-
sults from other traits were brieﬂy summarized in Tables 3 and 4 (de-
tailed results organized in similar way to height can be found on our
web site: http://tgx.uc.edu/zg/polygen_selection).
3.2. Height: An example
3.2.1. GWA SNPs
From the GWA catalog we exacted 178 height SNPs. Effect size and
direction of 167 SNPs reported by (Lango Allen et al., 2010) were
available.
3.2.2. FST metrics
Our ﬁrst analysis of selection signatures was based on the FSTmetric.
Compared to the “null” SNPdistributions derived from the 5000 permu-
tation sets matched by ancestral allele frequencies, the distribution of
the overall FST of the height SNPs clearly had an increasedmean and var-
iance (Fig. 2A). The empirical p-value of the average of the overall FST
across the 178 height SNPs was 0.0088, indicating increased differenti-
ation of height SNPs amongpopulations compared to the genomic back-
ground (Fig. 3). The most signiﬁcant differentiation was observed
between African and European populations, as indicated by the high
mean FST (AFR_EUR) between these two continental populations (p-
value = 0.0004). The differentiation between African and Asian popu-
lations (AFR_ASN) was only marginally signiﬁcant (p-value = 0.034)
and no signiﬁcantly increased differentiation was observed between
Asian and European populations (ASN_EUR) or within the three conti-
nental populations.
3.2.3. Branch length analysis
Our second analysis estimated phylogenetic branch lengths using
OLS and ML. In general, the two methods gave similar results, though
theMLmethod tended to report more signiﬁcant p-values (Fig. 4). Sim-
ilar to the distribution of global FST, the total branch lengths estimated
from the height SNPswere signiﬁcantly longer than the “null” permuta-
tion SNPs (Fig. 2B). The most signiﬁcant elongated branch lengths were
observed along the African (AFR) and Eurasia (EUA) splits, whichmight
suggestmost of the differentiation in allele frequencies between African
and European or Asian populationswas accumulated during this period.
3.2.4. Correlation between effect sizes and strength of selection
We identiﬁed signiﬁcant correlation between the allele frequency ad-
justed effect sizes βq(1 − q) and the strength of selection inferred by
overall FST or the total branch lengths. Based on linear regression
(Fig. 5), the allele frequency adjusted effect sizes explained approximately
12.5% (p-value = 2.6 × 10−6) and 12.7% (p-value = 2.3 × 10−6) of
the total observed variances in the overall FST and the total branch
lengths respectively. The rank correlation test (Kendall's tau) reported
even more signiﬁcant p-values (8.7 × 10−7 and 6.0 × 10−8).
3.2.5. Tests for directional changes
Among the 167 SNPs with effect size and direction information,
derived alleles of 95 SNPs increase height and 72 SNPs decrease height
(binomial p-value = 0.088). Based on the 1000 Genomes data, we did
not observe signiﬁcant differences of the derived allele frequencies be-
tween these two sets of SNPs among the threemajor continental popu-
lations (Fig. 6). Our ML estimation of branch lengths also enabled
estimation of allele frequencies in ancestral populations, and again, we
Table 2
The 38 complex traits/diseases.
Trait Totala Selectedb Effectc
records snps pubs records snps snps PMID
Physical traits
Height 425 385 19 265 178 167 20881960
Body mass index 112 102 16 64 35 30 20935630
Systolic blood pressure 30 29 3 25 23 17 21909115
Diastolic blood pressure 32 30 3 28 22 16 21909115
Lipids
Cholesterol, total 67 65 2 61 50 44 20686565
LDL cholesterol 104 76 13 85 36 29 20686565
HDL cholesterol 119 96 12 104 47 44 20686565
Triglycerides 98 78 11 83 33 30 20686565
Other metabolites and physiological traits
Urate levels 70 63 8 32 29 29 23263486
C-reactive protein 54 46 8 33 18 17 21300955
Adiponectin levels 48 44 9 28 16 14 22479202
Liver enzyme levels (gamma-glutamyl transferase) 26 26 1 25 25 25 22001757
Platelet counts 74 70 3 55 53 53 22139419
Ventricular conduction 25 25 1 23 23 23 21076409
QT interval 74 68 7 34 18 13 19305408
Corneal structure 32 31 3 27 27 25 23291589
Inﬂammatory and autoimmune disorders
Inﬂammatory bowel disease 124 118 4 116 108 107 23128233
Crohn's disease 212 172 14 168 95 65 21102463
Ulcerative colitis 129 101 8 92 57 41 21297633
Celiac disease 50 43 3 32 27 16 20190752
Systemic lupus erythematosus 111 90 12 52 29 16 19838193
Rheumatoid arthritis 96 78 14 42 28 15 20453842
Psoriasis 44 36 7 22 16 7 20953190
Multiple sclerosis 166 146 15 60 48 45 21833088
Type 1 diabetes 97 78 10 60 39 8 17554260
Primary biliary cirrhosis 41 32 4 21 17 14 21399635
Vitiligo 37 37 6 27 25 12 22561518
Common diseases
Type 2 diabetes 212 140 34 86 49 21 20581827
Coronary heart disease 150 127 20 55 35 24 21378990
Asthma 64 53 23 30 20 10 21804548
Parkinson's disease 84 67 15 32 16 9 21292315
Mental disorders
Schizophrenia 129 111 28 67 49 9 21926974
Bipolar disorder 128 115 19 56 42 15 21926972
Cancers
Breast cancer 76 61 24 33 19 8 20453838
Prostate cancer 116 82 21 70 34 9 18264097
Colorectal cancer 66 47 18 27 21 5 20972440
Menstruation related
Menarche (age at onset) 47 44 5 37 33 33 21102462
Menopause (age at onset) 40 34 3 23 18 17 22267201
a The number of association records (records), SNPs (snps) and publications (pubs) in GWA catalog.
b The number of records and SNPs that passed our selection criteria.
c The number of SNPs with effect size information (estimation and direction) and the PMID of the source article.
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frequencies of the height SNPs between ancestral and current popula-
tions (Online supplementary material).
3.2.6. Individual SNPs
Four height SNPs showed putative signal of selection, i.e. signiﬁcant-
ly large (p-value b 0.01) overall FST or total branch length (ML). The
most signiﬁcant one was rs1490384 on chromosome 6q22 near
CENPW gene. This SNP was also reported to be associated with tooth
eruption (Fatemifar et al., 2013). Another SNP was rs3791675 in the
EREMP1 gene, which was reported to be associated with growth rate
in children (Paternoster et al., 2011). The other two signiﬁcant SNPs
(rs9835332 and rs143384) are located in FAM208A (also known as
RAP140) and GDF5 gene, respectively. Both genes showed evidence
of recent selection, particularly the GDF5 gene, which was highlysigniﬁcant in iHS analysis and had been suggested to be under positive
selection in East Asians (Wu et al., 2012).
3.3. Selection signatures of other complex traits
3.3.1. BMI and blood pressure
In addition to body height, we examined three other physical quan-
titative traits (BMI, systolic and diastolic blood pressures). Overall, we
did not detectmajor signatures of selection from the collective analyses
of the GWA SNPs of these traits, although the blood pressure SNPs
showed accelerated differentiation among the four European popula-
tions (FST (EUR) p-value = 0.0022 and 0.0054 respectively, for SBP
and DBP). At the individual SNP level, none of the BMI SNPs had empir-
ical p-value (for overall FST or total branch length) less than 0.01. A non-
synonymous SNP (rs3184504 in SH2B3 gene) associated with blood
Table 3
Empirical p-values of the mean FST and branch length measures estimated from the GWA SNPs.
Trait Number of
SNPs
Empirical p-values of FST
measures
Empirical p-values of branch length measures
Global Average AFR_ASN AFR_EUR ASN_EUR AFRs ASNs EURs Total AFR EUA ASN EUR AFRs ASNs EURs
Physical traits
Height 178 167 0.0088 0.004 0.0336 0.0004 0.283 0.799 0.111 0.713 0.0092 0.0004 0.0428 0.657 0.0808 0.664 0.1 0.713
Body mass index 35 30 0.326 0.618 0.645 0.288 0.301 0.676 0.912 0.823 0.588 0.328 0.762 0.276 0.527 0.823 0.882 0.803
Systolic blood pressure 23 17 0.341 0.608 0.77 0.446 0.141 0.771 0.877 0.0022 0.27 0.686 0.715 0.315 0.05 0.646 0.787 0.0036
Diastolic blood pressure 22 16 0.554 0.798 0.944 0.611 0.2 0.876 0.632 0.0054 0.581 0.919 0.861 0.384 0.103 0.794 0.656 0.0082
Lipids
Cholesterol, total 50 44 0.219 0.731 0.241 0.317 0.459 0.296 0.164 0.0032 0.111 0.0964 0.425 0.435 0.599 0.419 0.163 0.002
LDL cholesterol 36 29 0.679 0.807 0.541 0.773 0.471 0.128 0.089 0.953 0.678 0.439 0.738 0.552 0.596 0.2 0.148 0.986
HDL cholesterol 47 44 0.233 0.256 0.389 0.668 0.0732 0.531 0.094 0.158 0.28 0.302 0.881 0.136 0.331 0.473 0.117 0.22
Triglycerides 33 30 0.0094 0.0146 0.0042 0.168 0.179 0.0382 0.0032 0.409 0.0016 0.0072 0.0304 0.0374 0.866 0.0386 0.0126 0.342
Metabolites and physiological traits
Urate levels 29 29 0.0082 0.0226 0.117 0.073 0.0226 0.953 0.643 0.0348 0.0204 0.266 0.357 0.0192 0.042 0.925 0.658 0.032
C-reactive protein 18 17 0.366 0.168 0.335 0.409 0.285 0.0294 0.325 0.0586 0.349 0.487 0.549 0.282 0.583 0.0684 0.522 0.081
Adiponectin levels 16 14 0.887 0.971 0.629 0.992 0.679 0.496 0.88 0.26 0.929 0.9 0.877 0.667 0.761 0.446 0.692 0.177
Ggamma-glutamyl transferase 25 25 0.294 0.411 0.136 0.626 0.301 0.0402 0.434 0.184 0.259 0.298 0.501 0.149 0.788 0.0714 0.377 0.218
Platelet counts 53 53 0.618 0.859 0.434 0.332 0.884 0.438 0.0784 0.277 0.348 0.0576 0.595 0.748 0.845 0.458 0.0224 0.307
Ventricular conduction 23 23 0.772 0.827 0.904 0.717 0.653 0.149 0.239 0.109 0.787 0.841 0.813 0.768 0.532 0.137 0.165 0.113
QT interval 18 13 0.294 0.23 0.904 0.0896 0.243 0.598 0.136 0.939 0.553 0.483 0.668 0.542 0.214 0.539 0.179 0.952
Corneal structure 27 25 0.37 0.32 0.36 0.324 0.45 0.516 0.777 0.0024 0.336 0.517 0.268 0.439 0.659 0.286 0.808 0.0024
Inﬂammatory and autoimmune disorders
Inﬂammatory bowel disease 108 107 0.122 0.122 0.232 0.127 0.33 0.237 0.15 0.164 0.089 0.0764 0.384 0.201 0.451 0.311 0.196 0.298
Crohn's disease 95 65 0.0898 0.178 0.556 0.299 0.0188 0.197 0.113 0.032 0.131 0.643 0.935 0.0154 0.0654 0.176 0.0824 0.18
Ulcerative colitis 57 41 0.478 0.457 0.268 0.91 0.125 0.584 0.0608 0.58 0.437 0.641 0.84 0.0674 0.506 0.618 0.0608 0.68
Celiac disease 27 16 0.141 0.186 0.55 0.0352 0.177 0.708 0.658 0.805 0.125 0.0622 0.566 0.123 0.215 0.649 0.723 0.825
Systemic lupus erythematosus 29 16 0.008 0.0554 0.0328 0.0028 0.396 0.367 0.292 0.27 0.0072 0.0268 0.001 0.322 0.559 0.322 0.199 0.217
Rheumatoid arthritis 28 15 0.399 0.415 0.264 0.719 0.299 0.375 0.0542 0.336 0.42 0.388 0.717 0.422 0.419 0.324 0.115 0.297
Psoriasis 16 7 0.0952 0.167 0.087 0.167 0.462 0.218 0.0842 0.581 0.215 0.099 0.347 0.413 0.707 0.159 0.147 0.586
Multiple sclerosis 48 45 0.707 0.472 0.341 0.887 0.422 0.626 0.0212 0.258 0.585 0.857 0.505 0.465 0.462 0.681 0.038 0.292
Type 1 diabetes 39 8 0.0458 0.0994 0.528 0.0956 0.013 0.18 0.107 0.167 0.0334 0.423 0.408 0.0918 0.0248 0.104 0.0318 0.174
Primary biliary cirrhosis 17 14 0.18 0.199 0.156 0.495 0.306 0.823 0.272 0.0652 0.143 0.0694 0.777 0.08 0.742 0.78 0.18 0.0206
Vitiligo 25 12 0.0262 0.642 0.812 0.0234 0.0394 0.955 0.197 0.0036 0.0086 0.269 0.344 0.0808 0.0046 0.839 0.0734 0.0028
Common diseases
Type 2 diabetes 49 21 0.0354 0.151 0.221 0.121 0.0894 0.508 0.32 0.332 0.0264 0.404 0.0386 0.103 0.0672 0.354 0.395 0.279
Coronary heart disease 35 24 0.133 0.129 0.468 0.0338 0.385 0.601 0.321 0.103 0.0712 0.0416 0.233 0.554 0.266 0.775 0.099 0.0996
Asthma 20 10 0.225 0.194 0.36 0.499 0.148 0.951 0.733 0.147 0.269 0.243 0.729 0.155 0.235 0.929 0.738 0.132
Parkinson's disease 16 9 0.804 0.899 0.918 0.571 0.556 0.763 0.288 0.0482 0.637 0.719 0.793 0.621 0.459 0.695 0.0644 0.043
Mental disorders
Schizophrenia 49 9 0.0164 0.0114 0.0048 0.0026 0.556 0.31 0.297 0.381 0.0068 0.0004 0.0258 0.557 0.606 0.289 0.293 0.333
Bipolar disorder 42 15 0.63 0.595 0.758 0.707 0.448 0.348 0.144 0.0112 0.582 0.803 0.822 0.689 0.269 0.224 0.044 0.0264
Cancers
Breast cancer 19 8 0.298 0.233 0.253 0.607 0.18 0.708 0.434 0.949 0.364 0.645 0.506 0.0756 0.299 0.731 0.454 0.919
Prostate cancer 34 9 0.0174 0.0296 0.045 0.0036 0.449 0.777 0.042 0.405 0.01 0.0002 0.119 0.38 0.682 0.717 0.0176 0.24
Colorectal cancer 21 5 0.234 0.165 0.259 0.257 0.385 0.0662 0.0006 0.096 0.0648 0.171 0.225 0.261 0.429 0.109 0.0104 0.143
Menstruation related
Menarche (age at onset) 33 33 0.828 0.801 0.715 0.924 0.461 0.905 0.615 0.605 0.799 0.851 0.697 0.567 0.231 0.954 0.659 0.696
Menopause (age at onset) 18 17 0.324 0.218 0.451 0.24 0.256 0.837 0.848 0.236 0.402 0.52 0.271 0.378 0.358 0.829 0.634 0.352
* Signiﬁcant p-values (b0.01) are highlighted in bold. 83
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Table 4
List of GWA SNPs with top signiﬁcant signals of accelerated differentiation.
Note: SNPs in close LD are highlighted in gray blocks. Signiﬁcant iHS scores (|iHS| N 2.0) are printed in bold.
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Fig. 2. Distributions of the global FST (left) and the total branch length (right) estimated from the height GWA SNPs (red) in contrast to genome background (blue).
85G. Zhang et al. / Applied & Translational Genomics 2 (2013) 78–94pressure showed signiﬁcant differentiation betweenEuropean andnon-
European populations (FST p-value = 0.0042; branch length p-
value = 0.0088). The derived allele (T) was rare in African and Asian
populations (q = 0.03 and 0.01) but had high minor allele frequency
(q = 0.47) in the European population. Another similar but less signif-
icant example was an intronic SNP (rs1378942) in CSK gene, whose
derived allele frequency (A) was high in EUR but low in ASN and rare
in AFR.
3.3.2. Lipids traits
Among the four lipid traits, the most signiﬁcant selection signal was
observed in triglycerides (TG) SNPs. The overall FST and total branch
length of TG SNPs were signiﬁcantly higher than genome-wide average
with empirical p-value = 0.0094 and 0.0016, respectively. Even more
signiﬁcant differentiation was observed between African and Asian
populations (FST (AFR_ASN) p-value = 0.0042) andwithin Asian popu-
lations (FST (ASN) p-value = 0.0032). Branch length analysis suggested
accelerated differentiation along the African (p-value = 0.0072) and
Eurasia (p-value = 0.030) split and Asian split (p-value = 0.037), but
not the European split (p-value = 0.866). Several distinct TG SNPs
(rs7819412 of XKR6 gene and rs11649653 near CTF1) showed high de-
rived allele frequency in Asian but intermediate frequency in European
and low frequency in African populations. The HDL SNPs also showed
some level of increased differentiation among the Asian populations,Fig. 3. Box plots of mean FST estimated from the randomly selected permutation sets of SNPs (ge
numbers in parentheses are the empirical p-values.but did not reach nominal signiﬁcance in empirical tests. The individual
signiﬁcant HDL SNPs (e.g. rs386000, rs3136441 and rs7255436) shared
similar but less signiﬁcant pattern of elevated derived allele frequencies
in Asian populations. In contrast, the individual signiﬁcant SNPs (e.g.
rs7570971 in RAB2GAP1 gene and rs11065987) found in total cholester-
ol or LDL had more distinct higher derived allele frequencies in
Europeans but low frequencies in both Africans and Asians. The
rs11065987 near the BRAP and ATXN2 gene was associated with both
LDL and TC and has been reported to be a risk SNP of Tetralogy of Fallot
(Cordell et al., 2013). In addition, increased differentiationwas observed
in TC SNPs in European populations (FST (EUR) p-value = 0.003).3.3.3. Other metabolites and physiological traits
In the study of several other metabolites and physiological traits, we
detected signiﬁcant overall selection signature in GWA SNPs associated
with serum urate level (FST (ALL) p-value = 0.008). Nominally signiﬁ-
cant differentiation was observed between European and African/
Asian populations and within European populations particularly along
path to the TSI population (Tuscans from Italy). The identiﬁed strength
of selection was also signiﬁcantly correlated with the reported effect
sizes of the urate SNPs. Individually signiﬁcant SNPs include rs675209
near the RREB1 gene and rs653178 in the ATXN2 gene. The later SNP
has been reported as associated with blood pressure (Newton-Chehnome background) and themean FST estimated from the height GWA SNPs (red dots). The
Fig. 4. Box plots of mean branch lengths estimated by either OLS (top) or ML (bottom) from the randomly selected permutation sets of SNPs (genome background) and themean branch
lengths estimated from the height GWA SNPs (red dots). The numbers in parentheses are the empirical p-values.
86 G. Zhang et al. / Applied & Translational Genomics 2 (2013) 78–94et al., 2009; Wain et al., 2011), celiac disease (Dubois et al., 2010; Hunt
et al., 2008) and chronic kidney disease (Kottgen et al., 2010).
The 53 GWA SNPs associated with platelet counts did not show sig-
niﬁcant signatures of selection, but one of the most signiﬁcantly associ-
ated SNP — rs3184504 in SH2B3 showed a signiﬁcant difference in
derived allele frequency between European and non-European popula-
tions. This SNP was also signiﬁcantly associated with other blood cell
traits (Gudbjartsson et al., 2009; Tin et al., 2013; van der Harst et al.,
2012), blood pressure (International Consortium for Blood Pressure
Genome-Wide Association, S., et al., 2011; Levy et al., 2009) and cardio-
vascular risks (Gudbjartsson et al., 2009; International Consortium for
Blood Pressure Genome-Wide Association, S., et al., 2011; Schunkert
et al., 2011), multiple autoimmune disorders, such as type 1 diabetes
(Barrett et al., 2009; Plagnol et al., 2011), rheumatoid arthritis (Stahlet al., 2010), celiac disease (Izzo et al., 2011), multiple sclerosis (Alcina
et al., 2010), hypothyroidism (Eriksson et al., 2012), etc. This variant
had been reported in previous natural selection studies (Ding and
Kullo, 2011; Pickrell et al., 2009; Sabeti et al., 2006; Zhernakova et al.,
2010).
We did not observe signiﬁcant selection signature from the collec-
tive analyses of 18 C-reactive protein (CRP) SNPs and none of the
SNPs individually showed signiﬁcant differentiation among the studied
populations. Similar negative results were obtained from the analysis of
25 GWA SNPs of liver enzyme levels (gamma-glutamyl transferase,
GGT) or the 16 GWA SNPs associated with adiponectin levels. However,
the 14 adiponectin SNPs with effect information showed signiﬁcantly
unbalanced effects— the derived alleles of 13 SNPs have negative effects
on adiponectin levels. The allele frequency differences of these SNPs
Fig. 5. Dot plots between the allele frequency adjusted effect size and the global FST (left) or total branch length (right) of the height GWA SNPs.
87G. Zhang et al. / Applied & Translational Genomics 2 (2013) 78–94between African and European population seemed to be small (FST
(AFR_EUR) p-value = 0.992). The analysis of GWA SNPs associated
the two electrophysiology traits (ventricular conduction and QT inter-
val) yielded no signiﬁcant results. Negative results were also observed
in the 27 SNPs associated with corneal thickness, although signiﬁcant
differentiation among European populations was observed.3.3.4. Inﬂammatory and autoimmune disorders
Eleven inﬂammatory and autoimmune disorders were examined, in-
cluding inﬂammatory bowel disease (IBD) and its subforms, (i.e. Crohn's
disease, ulcerative colitis (UC)), celiac disease (CD), systemic lupus ery-
thematosus (SLE), rheumatoid arthritis (RA), psoriasis, type 1 diabetes
(T1D),multiple sclerosis (MS), vitiligo andprimary biliary cirrhosis (PBC).
Among the inﬂammatory and autoimmune disorders the most
signiﬁcant collective selection signatures were obtained in GWA
SNPs associated with SLE and vitiligo. The 29 SLE SNPs were signiﬁ-
cant for both global FST (p-value = 0.008) and branch length analy-
ses (p-value = 0.0072). Most of the differentiation in SLE SNPs allele
frequencies was driven by differences between African and European
populations (FST (AFR_EUR), p-value = 0.0028) or the Eurasia split in
branch length analysis (p-value = 0.001). A risk SNP (rs6705628)
identiﬁed in Asian samples (Yang et al., 2013) had a low derived alleleFig. 6. Frequency distributions of derived alleles (blue: alleles with positive effect; red: alleles w
bers of derived alleles with positive (+) or negative (−) effect and the Wilcoxon test p-valuesfrequency in European (q = 0.01) but high frequency in Africans
(q = 0.36) and Asians (q = 0.19).
Signiﬁcant selection signatures were detected in the collective analy-
sis of the 25 GWA SNPs associated vitiligo (global FST p-value = 0.0262
and the total branch length p-value = 0.0086). Between populations
FST and branch length analysis demonstrated these signiﬁcant signals
were mainly driven by accelerated allele frequency changes along the
European ancestry (branch length, EUR p-value = 0.0046) or the subdi-
vision of different European populations (branch length, EURs p-
value = 0.0028). Individual SNP analyses revealed signiﬁcant selection
signals in a SNP (rs4766578) in the ATXN2 gene and a 3′UTR SNP
(rs1129038) inHERC2 gene. The ATXN2 (and the nearby SH2B3 gene) ap-
peared as a candidate region that contains multiple GWA SNPs showing
signiﬁcant selection signature. The second SNP (rs1129038) is part of a
haplotype spanning the OCA2 and the HERC2 gene, signiﬁcantly associat-
ed with hair and eye colors (Candille et al., 2012; Donnelly et al., 2012;
Eiberg et al., 2008; Kayser et al., 2008).
The collective analyses of the 108 IBD GWA SNPs as well as 95
Crohn's disease and 57 UC GWA SNPs did not show signiﬁcant signa-
tures of selection, although marginally elevated FST were observed be-
tween or within Asian and European populations in SNPs associated
with Crohn's disease or UC. Individual SNP analysis showed that the de-
rived allele frequencies of several risk SNPs (e.g. rs12103, rs670523,ith negative effect) of the height GWA SNPs in the three continental populations. The num-
(in parentheses) are shown above the ﬁgures.
88 G. Zhang et al. / Applied & Translational Genomics 2 (2013) 78–94rs2472649, rs7517810 and rs11150589) were elevated in European or
Asian populations, but the effects of the derived alleles of these SNPs
pointed in both directions (either increasing or decreasing the risks), in-
consistent with a common pattern of directional selection among
populations.
The analysis of 27 CDGWA SNPs also did not reveal anymajor selec-
tion signatures, except for a marginally signiﬁcant difference between
African and European populations (FST (AFR_EUR), p-value = 0.035).
Two CD SNPs were signiﬁcant in individual SNP analysis: rs13003464
in PUS10 and rs653178 in ATXN2. The ﬁrst one was also associated
with Crohn's disease (Kenny et al., 2012) and the second one had ap-
peared before in our analysis of uric acid GWA SNPs. Rs653178 was
also in close linkage disequilibriumwith rs3184504, whichwas a signif-
icant SNP associatedwith platelet counts andmany other disorders (see
above).
The T1D GWA SNPs showed marginal signiﬁcance in overall FST (p-
value = 0.046) and branch length analysis (p-value = 0.033), but
more signiﬁcant differentiation was observed between Asian and
European populations. Branch length analysis also indicated accelerated
differentiation of T1D SNPs after the European population split from
Eurasia (p-value = 0.025). Two T1D SNPs (rs9388489 and rs3184504)
were signiﬁcant in individual SNP analysis. The ﬁrst one (rs9388489) is
near rs1490384 — a height SNP with sign of selection; and the second
one (rs3184504 in SH2B3) is associated with multiple complex traits.
The analysis of 48MS SNPs showed no signiﬁcant ﬁnding except for
a marginally increased difference within the Asian populations (FST
(ASN), p-value = 0.021). The individual SNP with most signiﬁcant se-
lection signal (rs7923837 in HHEX) was also associated with Type 2 di-
abetes (Cai et al., 2011; Staiger et al., 2007), particularly signiﬁcant in
Asian populations (Horikoshi et al., 2007).
Collective analysis of GWA SNPs associated with RA, psoriasis and
PBC did not show signiﬁcant collective signature of selection. A PBC as-
sociated SNP (rs968451) near PDGFB were in close linkage disequilibri-
um with rs2413583, which is associated with IBD and Crohn's disease.
3.3.5. Other complex disorders
The analysis of 49 type 2 diabetes (T2D) suggested marginally in-
creased differentiation of T2D SNPs among populations (FST (ALL) p-
value = 0.0354), which was likely attributed to the Eurasia split from
Africa. The individual T2D SNP showingmost signiﬁcant selection signal
was rs8042680 in PRC1 gene, which has a high derived allele (protec-
tive) frequency in European but is rare in African and absent in Asian.
The analysis of 35 coronary heart disease (CHD) did not show
overall increased differentiation among populations (overall FST p-
value = 0.133), except for a marginal increase between African
and European populations (FST (AFR_EUR), p-value = 0.034). The
individual CHD SNP showing most signiﬁcant selection signal was
rs599839 in PSRC1 gene, which was also signiﬁcantly associated
with LDL (Sandhu et al., 2008; Willer et al., 2008).
In the study of two mental disorders, we observed strong selection
signals in the 49 schizophrenia SNPs (global FST p-value = 0.016 or
total branch length p-value = 0.007). The most signiﬁcant allele fre-
quency differences of schizophrenia SNPs were observed between
African and non-African populations (FST (AFR_ASN), p-value = 0.0048,
FST (AFR_EUR), p-value = 0.0026) and were mostly attributed to the
African (AFR p-value = 0.0004) and Eurasia (EUA p-value = 0.026)
splits in branch length analysis. The 42 bipolar SNPs did not show overall
increased allele frequency differences among populations, however, the
differences among European populations was signiﬁcant (FST (EUR), p-
value = 0.011).
3.3.6. Cancers
We examined GWA SNPs associated with three different types of
cancers (breast, prostate and colorectal cancers). The most signiﬁcant
collective evidence of population differentiations was observed in the
34 SNPs associated with prostate cancer (global FST p-value = 0.017or total branch length p-value = 0.01). Much of the differentiation was
mapped to the African lineage in the ML branch length analysis (p-val
(AFR) = 0.0002). Two signiﬁcant SNPs (rs1465618, rs103294) are
located in THADA and near LILRA3 gene, respectively. Multiple SNPs
(rs7590268, rs6732426, rs13429458, rs17030845, rs12478601,
rs7578597 and rs10495903) in the THADA gene have been reported
to be associated with various complex traits or diseases: cleft palate
(Ludwig et al., 2012; Mangold et al., 2010), hair morphology (Medland
et al., 2009), polycystic ovary syndrome (Chen et al., 2011; Shi et al.,
2012), platelet counts (Gieger et al., 2011), type 2 diabetes (Zeggini
et al., 2008), IBD and Crohn's disease (Franke et al., 2010; Jostins et al.,
2012). This gene has also been reported as a gene under selection
(Ding and Kullo, 2011; Klimentidis et al., 2011; Pickrell et al., 2009).
The GWA SNPs associated with breast or colorectal cancers did not
show an overall signiﬁcant signature of selection. But there was a sign
of elevated differentiation of colorectal cancer SNPs among Asian popu-
lations (FST (ASN) p-value = 0.0006). The signiﬁcant colorectal cancer
SNP (rs4925386 in LAMA5 gene) has higher derived allele frequency
in Africans, but relatively low frequencies in Asians and Europeans.
iHS scores were also positive, suggesting selection on ancestral alleles,
which was a rare example of this kind in our list of signiﬁcant GWA
SNPs under selection (Table 4).
3.3.7. Menstruation related traits
We also examined two menstruation traits: age of onset of menar-
che and menopause. The evolutionary signiﬁcance of menstruation
has been hypothesized (Emera et al., 2012; Renfree, 2012; Stearns,
2012). However, our analysis of GWA SNPs associated with these two
traits did not reveal any signiﬁcant sign of selection, except for a single
variant, rs1361108, associated with age of menarche that showed sig-
niﬁcant allele frequency differences between populations. This variant
is in close LD with rs9388489 and rs1490384, associated with T1D and
height, respectively.
4. Discussion
The results of GWA studies suggest that most complex human traits
are highly polygenic (McCarthy et al., 2008; Stranger et al., 2011). As a
result, the effects of polygenic adaptation on genetic variants associated
with complex traits will be generally modest and will spread across
many loci (Hancock et al., 2010; Pritchard and Di Rienzo, 2010;
Pritchard et al., 2010). Therefore, in this current study, we aimed to
identify combined evidence for natural selection of complex traits by
aggregating selection signals across multiple GWA SNPs. Speciﬁcally,
for a complex trait, we examined 1)whether the GWASNPs collectively
show accelerated differentiation among populations; 2) in which
human lineage(s) the allele frequencies underwent signiﬁcant changes;
3) whether the strength of selection is correlated with the effect size of
the genetic variant; and 4)whether the changes in allele frequencies are
directional or not. Through analyses of nearly 1300 GWA SNPs associat-
ed with 38 complex traits, we revealed some general features of natural
selection on complex traits associated variants.
4.1. Selection signatures of complex traits
Among the 38 complex traits/diseases examined in this study, we
observed evidence for natural selection in many traits based on the col-
lective analyses of trait associated SNPs. The most notable examples
include: body height, serum urate levels; triglycerides (TG); multiple
autoimmune disorders, particularly SLE and vitiligo; schizophrenia;
and less signiﬁcantly, type 2 diabetes (T2D) and prostate cancer. For
those traits that did not reach our predeﬁned signiﬁcance level
(p-value b 0.01), the distribution of the global FST or total branch length
estimated from the GWA SNPs generally had higher mean and larger
variance than the random SNPs, supporting the hypothesis that natural
selection on variants associated with complex traits is a common
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Pritchard et al., 2010).
The most signiﬁcant example of combined signature of selection as
indicated by elevated mean global FST and total branch length was ob-
served in the 178 height association SNPs. This result generally agrees
with two recent studies (Amato et al., 2011; Turchin et al., 2012).
Amato et al. (2011) found a higher mean FST of the height SNPs based
on the HapMap data and Turchin et al. (2012) demonstrated systematic
allele frequency differences of height SNPs between Northern and
Southern Europeans, both indicating that natural selection may be
acting on the height associated SNPs. Our branch length analysis
partitioned the major differentiations to the early splits between
African and Eurasia lineages instead of more recent splits, suggesting
the selection force on these height SNPs is more of a factor early in
human migration. Anthropological evidences indicated there was a
body size decrease in humans 50,000 years ago possibly associated
with technological improvements in food production and climate
change (Ruff, 2002).
Our secondmost signiﬁcant examplewith collective evidence for se-
lection was urate levels — the mean global FST and total branch length
estimated from the 29urate SNPswere signiﬁcantly higher than permu-
tation sets. Unlike the height SNPs, signiﬁcant differentiations in allele
frequencies were observed between European and Asian populations
andwithin European populations particularly along path to the TSI pop-
ulation. Uric acid (UA) is the end product of purine metabolism and
humans have higher UA levels than other mammals due to the loss of
uricase activity. Despite its harmful effects, the evolutionary beneﬁts
of uric acid as an antioxidant and neuroprotector have been hypothe-
sized (Alvarez-Lario and Macarron-Vicente, 2010; Johnson et al.,
2005), and the selection upon urate SNPs may be associated with die-
tary changes (e.g. the intake of red meat and alcohol consumption).
Among the four lipid traits, we observed signiﬁcant evidence for se-
lection in the 33 SNPs associated with TG level. Based on our branch
length analysis, the selection signals dispersed across multiple popula-
tion lineages except for European populations. TG is the main way for
energy storage (Hegele, 2009) and has an essential role in human evo-
lution. The selection on TG associated variants may be relevant to phys-
iological adaptions to nutritional stress that modern humans have
experienced in evolution history (Nakayama et al., 2011). As compared
to other lipids, TGmay bemore associatedwith environmental changes
(i.e., diet) and may therefore play a role in changing diets over human
evolution.
We detected selection signatures in multiple inﬂammatory and au-
toimmune disorders. But compared to other physical or physiological
traits and complex diseases examined in this study, these autoimmune
disorders did not showenrichment or stronger signatures of selection as
suggested by recent studies (Barreiro and Quintana-Murci, 2010; Raj
et al., 2013). Among the eleven autoimmune disorders examined in
this study, the SNPs associated with SLE and vitiligo showed the stron-
gest evidence of allele frequency differentiation.
Evolutionary hypotheses such as the thrifty-genotype hypothesis
(Neel, 1962) and the ancestral-allele susceptibility model (Di Rienzo
and Hudson, 2005) have been proposed to explain the epidemiology
of complex diseases in the context of evolution. All these models impli-
cate genetic variants that have undergone positive selection during his-
torical periods but might be maladaptive in present day environment
and give rise to disease phenotypes (Biswas and Akey, 2006). Indeed,
we observedmarginally signiﬁcant (p-value b 0.05) signatures of selec-
tion in the analyses of GWA SNPs associated with type 2 diabetes (T2D)
and coronary heart disease (CHD), but the there are no consistent pat-
terns of selection that provide conclusive support to these evolutionary
hypotheses.
Severe mental disorders impart clear decreases in ﬁtness and as
such, why susceptible alleles to mental diseases are still maintained in
population is a paradox (Keller and Miller, 2006). In the analyses of
GWA SNPs associated with two major types of mental disorders, wefound signature of selection among the SNPs associated with schizo-
phrenia but not in the bipolar GWA SNPs, whichmight suggest different
evolutionary scenarios of these two mental disorders.
We also observed signiﬁcant signatures of selection in the SNPs asso-
ciated with prostate cancer and the accelerated differentiation was
mainly mapped to the African lineage. The SNPs associated with colo-
rectal cancer, although did not show more differentiation globally,
were signiﬁcantly more differentiated among Asians.
In summary, by aggregating evidence of population differentiation
across many GWA SNPs associated with a complex trait, we detected
signiﬁcant combined signatures of selection in variants associated
with many complex traits and diseases. These results were consistent
with (Adeyemo and Rotimi, 2010; Amato et al., 2009; Ding and Kullo,
2011; Kullo and Ding, 2007), which also showed genetic variants asso-
ciated with complex human diseases showwide variation across multi-
ple populations. The power of our method varies between different
traits due to the different numbers of identiﬁed GWA SNPs. In addition,
we used arithmetic mean to summarize the selection measures (i.e. FST
or branch length), whichwould average out real selection signals when
there are both directional (increase in FST) and balancing (decrease in
FST) selection in the same set of SNPs. Although compared to directional
selection, balancing selection might be less common (Akey et al., 2002)
and usually has a less signiﬁcant footprint (Beaumont and Balding,
2004). Indeed, we observed SNPs with unusually small differentiation
(suggesting balancing selection), such as a SNP associated with IBD
(rs12942547 in STAT3 gene, p-value = 0.998 in our one directional
test for increased differentiation). The same SNP has been reported to
be associated with both IBD and MS but with opposite effect (Cagliani
et al., 2011; Jostins et al., 2012). Recently, antagonistic pleiotropy was
suggested to drive the balancing selection of OLR1 gene in certain
human populations (Predazzi et al., 2013).
4.2. Selection signature along speciﬁc lineages of human populations
In addition to the FST analyses, we tried to partition the observed al-
lele frequency differences among different populations into particular
lineage(s) of human evolution by branch length analysis. Similar
methods have been proposed before (Pickrell and Pritchard, 2012;
Shriver et al., 2004). Based on a ﬁxed topology (Fig. 1A) supported by
both 1000 Genomes data and previous population genetics studies, we
used two different analytical methods to obtain the branch length esti-
mates: the OLSmethod based on pairwise FST and anMLmethod which
directly models allele frequency changes among related populations.
The results generated by these two methods were in close agreement,
except for some variations in the estimation of terminal branch lengths.
The estimated branch lengths can be thought of as an analogous to FST,
between a population and its hypothetical ancestor. Using this ap-
proach, we were able to map selection signals along speciﬁc population
evolutionary lineages.
Of the complex traits/diseases with signiﬁcant signatures of selec-
tion, the patterns of branch lengths and the associated empirical signif-
icances showed by the GWA SNPs vary between traits, indicating
different evolutionary history of different traits, or in otherwords recent
adaption of different complex traitsmight be associatedwith temporar-
ily and geographically speciﬁc environmental challenges. Furthermore,
we did not observe pervasive signiﬁcant branch length changes spread-
ing over the population tree, indicating the selection forces on a polygen-
ic trait vary both temporarily and geographically in human evolutionary
history. For example, the SNPs associatedwith height, SLE, schizophrenia
and prostate cancer showed most signiﬁcant differentiations between
African and European populations and the accelerated changes in allele
frequencies weremapped deeply to African-Eurasia splits. But the differ-
entiation in allele frequencies of SNPs associated with urate levels and
vitiligo seems having a relatively recent origin between the European
and the Asian split. There were also examples whose associated SNPs
expressed signiﬁcant differentiation within continental populations,
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structure and vitiligo were highly differentiated among European popu-
lations. But SNPs associatedwith triglycerides and colorectal cancerwere
increasingly differentiated among Asian populations.
Because of the highly stochastic nature of allele frequency changes
among populations, substantial uncertainty might exist in our branch
length estimation, particularly considering the number of variables
(number of branches) that need to be estimated is far more than the
number of observations (number of populations). Also, the population
tree model (Fig. 1) behind our branch analyses is an oversimpliﬁcation
of human population history, which assumes absolute geographical iso-
lation and ignores gene ﬂow (Pickrell and Pritchard, 2012). In addition,
individual SNPs associated with a particular trait might undergo differ-
ent evolutionary history and cannot be represented accurately by an
average pattern across multiple SNPs.4.3. Correlation between strength of selection and effect size
In several of the complex traits examined in this study, we detect-
ed signiﬁcant correlations between the reported effect sizes (allele
frequency adjusted) of the SNPs and the estimated FST (global) or
branch length (total). As the FST and branch length capture cumula-
tive genetic response to selection over generations, these measures
were used here as surrogate measures of the “strength of selection”.
The most signiﬁcant example again was height, the allele frequency
adjusted effect size βq(1 − q) was highly correlated with the
estimated global FST (p-value = 2.6 × 10−6) or total branch length
(p-value = 2.3 × 10−6) and it can explain a substantial fraction
(N10%) of the observed variance in FST or branch length among the
height GWA SNPs. This observation suggested that, at least in certain
periods of human evolution, strong genetic covariance might have
existed between height and ﬁtness, which enabled rapid polygenic
adaptation by allele frequency shifts at these height inﬂuencing var-
iants so that a new phenotypic optimum could be reached to meet
environmental challenge (Pritchard et al., 2010). Beyond this exam-
ple, similar but less signiﬁcant correlations between effect size and
“strength of selection” were observed in GWA SNPs associated with
serum urate level and diastolic blood pressure.
Polygenic adaptation is an inherentlymultivariate process and natu-
ral selection often acts upon sets of functionally related traits. Following
the classical quantitative genetics mode, allele frequency changes in re-
sponse to selection are determined by both selection gradients and ge-
netic correlations between all the traits under selection (Blows, 2007;
Lande, 1979; Lande and Arnold, 1983). Consequently, the observed
strong correlation between the effect sizes of SNPs associated a pheno-
typic trait and the “strength of selection” strongly suggest the pheno-
typic trait (e.g. height) has been the primary target of selection and
the allele frequency changes might have been driven by the selection
pressure on the trait (“focal” trait). Whereas for those traits in which
we did not observe any signiﬁcant correlation between effect size and
“strength of selection”, the selection might act through other traits
with shared genetic components due to pleiotropy (Mackay et al.,
2009).
Because the effect size on a “focal” trait (i.e. a trait with ﬁtness effect)
and the estimated “strength of selection” (i.e. FST or branch length)may
not necessary follow a linear relationship, we used Pearson's correlation
(for linear correlation) as well as Kendall's tau (for non-linear depen-
dence) to access the statistical signiﬁcance. Usually, the Kendall's tau re-
ported more signiﬁcant results (such as in SNPs associated with height
and urate level), indicating the quantitative relationship between the
effect size on a “focal” trait and the effect on ﬁtness is complex and can-
not be simply predicted by simple quantitative genetic models (Orr,
2009). We also observed examples in which the Pearson's correlations
weremore signiﬁcant (such as in SNPs associatedwith DBP and platelet
counts). However, it seems that the highly signiﬁcant linear correlationwas driven by a number of outliers (with both uncommonly large effect
size and between population differentiation).
4.4. Signs of directional selection
We used three different methods to examine whether there were
consistent signs of directional selection among the trait associated
SNPs. The ﬁrst two methods were based on the comparison of counts
or allele frequency distributions between derived alleles with plus or
minus effects. The thirdmethod took the advantages of the ancestral al-
lele frequencies estimates from our ML branch length analysis and di-
rectly compared the allele frequency changes between current and
ancestral populations. The validity of thesemethods depends on two as-
sumptions: ﬁrst, the mutant (derived) alleles have an equal chance to
have either plus or minus effect on a complex trait and second, the de-
tection rates of risk alleles with plus or minus effects were same by
GWA studies. The ﬁrst assumption was suggested by Fisher's inﬁnitesi-
mal model (Hill, 2010) and was supported by many studies (Gibson,
2011; Hill, 2010). The assumption of same detection rates of alleles
with plus or minus effects is generally true in the association studies
of quantitative traits with no sampling bias. But case/control studies of
less common complex diseases might favor detection of low-frequent
alleles that increase disease risk due to the enrichment of cases.
Nevertheless, we did not observe signiﬁcant evidence of directional
selection among most of the traits examined in this study, except for
adiponectin — most of the derived alleles (13 of14) of the associated
SNPs reduce the adiponectin level (p-value = 0.0018).
Again, using height as an example, we did not observe systematic al-
lele frequency changes that favor either increase or decrease of height in
the three continental populations. These observations might suggest
that, although the differentiation between populations was accelerated
by selection forces, the trajectories or the directions of allele frequency
changes were highly stochastic. This observation is in line with Amato
et al. (2011), who suggested the behavior of frequency changes of al-
leles under (balancing) selection resembles a statistical mechanics phe-
nomenon called Spontaneous Symmetry Breaking (SSB), in which case
the allele frequencies of trait inﬂuencing alleles are randomly driven
by selection in different populations and modiﬁed stochastically by
the initial condition and demographic events. The overall outcome is
an increase of diversity among populations (i.e. high FST) but not pre-
dictable trajectories of allele frequency changes. However, the study
by Turchin et al. (2012) demonstrated evidence of directional changes
in allele frequencies of height SNPs between Northern Europeans and
Southern Europeans, which might be governed by the deterministic
force of directional selection (Fu and Akey, 2013).
Another possible explanation of this “drifting” (non-directional) pat-
tern of allele frequency changes under selection could be the temporal
or spatial ﬂuctuation in ﬁtness (Miura et al., 2013; Orr, 2009). For exam-
ple, a genotype might enjoy high ﬁtness and the allele frequency in-
creases over a short time period or in a reﬁned geographical region;
but in another time period or region the same genotype might have
low ﬁtness and the frequency decreases. Over a longer time-scale or
broader regions, the genotype might seem to be selectively “neutral”
on average but the rate of frequency “drift” (changes without predict-
able directions) could be speeded-up by natural selection. This explana-
tion might also answer why Turchin et al. (2012) detected directional
changes in allele frequencies of height SNPs but we did not — because
the European populations they studied represent a short time-period
in human evolution and locate in reﬁned geographical regions, in
which the selection forcemight bemore homogenous. Besides this pos-
sibility, stabilizing selection and assortative mating might also increase
differentiation among populations (i.e. high FST) but not necessarily
lead to directional changes in allele frequencies.
Despite the fact that the power of our tests to detect directional se-
lection was limited by the number of available GWA SNPs, we believe
the negative results obtained from the analysis of directional changes
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natural selection of complex traitsmight be highly stochastic. That is, al-
though collectively signiﬁcant signatures of natural selection on a com-
plex trait might be evident, the long-term response to selection might
be unpredictable because a myriad of different selection mechanisms
and various environmental challenges and demographic factors fueled
the process. This conclusion might have an implication in complex dis-
ease genetics study: association mapping in different populations is
likely to reveal different sets of trait associated SNPswith prominent ev-
idence of population differentiation; however, the allele frequency dif-
ferences in these trait associated SNPs may not follow a simple
evolution model and cannot be mechanistically interpreted as the out-
come of local adaption in different populations (i.e. disease prevalence).
This conjecture was also supported by Southam et al. (2009), who did
not ﬁnd consistent patterns of selection among the T2D and obesity sus-
ceptibility variants to support the thrifty genotype hypothesis.
4.5. Individual SNPs under selection
Among the 1296 distinct SNPs associatedwith the 38 complex traits,
we identiﬁed 36 SNPswith signatures of divergent selection as reﬂected
by signiﬁcantly higher global FST or total branch length at p-
value b 0.01, reﬂecting an excess of hits expected by chance alone
(Table 4). Nearly half of the identiﬁed SNPs showed signiﬁcant iHS
scores (Voight et al., 2006) (|iHS| N 2.0), and most of them were nega-
tive (iHS b −2) in European or Asian populations, indicating the de-
rived alleles are under selection in these two populations. Some of the
signiﬁcant SNPs associated with different complex traits are clustered
together. For example: rs9388489 (T1D), rs1361108 (menarche, age
at onset) and rs1490384 (height) near the CENPW gene; rs386000
(HDL) and rs103294 (prostate cancer) near the LILRA3 gene; andmulti-
ple trait associated SNPs at the SH2B3-ATXN2 locus were respectively in
near perfect LD. This clustering pattern may indicate that some loci
under selection have pleiotropic effects onmultiple apparently unrelat-
ed complex traits (Sivakumaran et al., 2011;Wagner and Zhang, 2011).
Alternatively, the extended LD between multiple trait associated vari-
ants at a locusmight be a result of hitchhiking effect of a major selective
sweep (McVean, 2007).
Some of the identiﬁed SNPs were in genomic loci with well-
established evidence of natural selection, such as the SH2B3-ATXN2
locus (Sabeti et al., 2006; Zhernakova et al., 2010) and the OCA2-
HERC2 locus (Donnelly et al., 2012). The SH2B3-ATXN2 locus contains
GWA SNPs associated with many complex traits and disorders, includ-
ing various auto-immune disorders (Barrett et al., 2009; Dubois et al.,
2010; Jin et al., 2012; Stahl et al., 2010), blood cell traits (Gieger et al.,
2011; Gudbjartsson et al., 2009; van der Harst et al., 2012), blood pres-
sure (International Consortium for Blood Pressure Genome-Wide Asso-
ciation, S., et al., 2011; Levy et al., 2009), urate level (Kottgen et al.,
2013), cholesterol (Teslovich et al., 2010)) and CHD (Schunkert et al.,
2011), etc. The reported GWA SNPs within this locus (rs3184504,
rs4766578, rs653178 and rs11065987) are in close LD and the derived
alleles of these SNPs formed a haplotype associated with increased
risk to auto-immune disorders and increased blood pressure, urate
level but reduced cholesterol. This haplotype of derived alleles is com-
mon in the European population but rare in Africans and Asians. Evolu-
tionary analysis has suggested a recent selective sweep in SH2B3 in the
European populations in response to possible bacterial infection
(Zhernakova et al., 2010). It should be noted that the haplotype of the
SH2B3-ATXN2 locus extends to the nearby ALDH2 gene, which has also
been suggested to be under selection (Oota et al., 2004). Genetic vari-
ants of OCA2-HERC2 locus are associated with eye and hair pigmenta-
tion (Eiberg et al., 2008; Kayser et al., 2008; Liu et al., 2010; Sulem
et al., 2007). The variant (rs1129038) associated with vitiligo is in
close LD with the variants that associated with eye or hair color (i.e.
rs12913832, rs916977 and rs1667394). These variants are common in
European population but rare in African and Asian. A third examplewas a SNP associated with total cholesterol (rs7570971) in RAB3GAP1
gene. This gene locates near LCT gene (Bersaglieri et al., 2004) and the
derived allele (C) of rs7570971 that reduces cholesterol exists almost
exclusively on the haplotype that is associated with lactase persistence,
which is common in Europeans but rare and absent in African and Asian
populations, respectively.
In addition to these examples, ﬁve SNPs associated (rs12103,
rs7517810 (tagged by rs9286879), rs11150589, rs2472649, rs670523)
with IBD or its subforms (i.e. Crohn's disease, ulcerative colitis (UC))
showed signiﬁcant evidence of divergent selection (Table 4). These
SNPs were found in the top 8 signiﬁcant SNPs under directional selec-
tion (with p-value b 0.01) identiﬁed by Jostins et al. (Supplementary
Table 5 of reference (Jostins et al., 2012)) and the ranking of signiﬁcance
of these SNPs were almost same between the two studies. Two of the
other three signiﬁcant loci reported by Jostins et al. (rs7608910/
rs13003464 and rs6088765/rs2425019) were also located or near
SNPs under signiﬁcant selection identiﬁed by our study, although not
reported as IBD associated SNPs: rs13003464 was listed as a Celiac dis-
ease associated SNP and rs6088765 was near the UQCC/GDF5/CEP250
height associated region indexed by rs143384. Our results were also
consistent with Ding and Kullo (2011), who studied differentiation in
allele frequencies of SNPs associated with cardiovascular diseases.
Most of the signiﬁcant SNPs reported in their study were replicated in
our study either among our top signiﬁcant list (Table 4) orwithmargin-
al signiﬁcance (p-value b 0.05). The consistency of the identiﬁed selec-
tion signals between our analysis and previous studies provides support
to our approach and the power of using 1000 Genome data in detecting
selection signatures. The per-variant selection data used by Jostins et al.
(2012) were generated by the TreeMix (Pickrell and Pritchard, 2012),
which measures the extent of differentiation of allele frequencies
among populations, is similar to our branch length analysis. The study
by Ding and Kullo (2011) was mainly based on FST analysis. However,
both of these two previous studies used the Human Genetic Diversity
Panel data from more than 50 populations, which is more diverse than
the 1000 Genome data.
4.6. Limitations
It should benoted that the source data andour analytical approaches
are subject to some limitations. First, our current study relies on the re-
cords of SNP-trait associations extracted from the GWA catalog
(Hindorff et al., 2009). Although it contains the most comprehensive
list of SNP associations of complex traits, the number and quality of
the reported associations in the GWA catalog vary among published
GWA studies. To assure the quality of extracted records, we only includ-
ed GWA SNPs with stringent p-value (b5 × 10−8) reported by large
studies (sample size N 1000). Because of the large number of extracted
records (nearly 1500), we could not check the original reports to verify
the accuracy of the records. More importantly, the reported GWA SNPs
were mostly detected using commercial genotyping chips in samples
usually of European origin and in combination the identiﬁed SNPs
only explain a very small fraction of the phenotypic variance. Thus,
the GWA SNPs may not provide a representative picture of the entire
underlying genetic architecture of complex traits. Consequently, the se-
lection signatures of complex traits detected in our current study are in-
complete and probably biased in certain ways. For example, a negative
result based on the known SNPs of a complex trait does not necessarily
mean there is no polygenic adaptation of the trait. With the accumula-
tion of extended sets of GWA SNPs of complex traits by larger studies
in diverse populations, we will obtain a more complete picture of poly-
genic adaption of complex traits.
Second, our approaches to detect natural selection were based on
the comparison of allele frequency differences between populations
and therefore cannot capture signals of selection before the human mi-
gration out of Africa (50,000 to 75,000 years ago) (Sabeti et al., 2006).
Future investigation using other statistical methods (Biswas and Akey,
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might help identify selection signatures on different time scales or at
different stages of a selective sweep. Single-locus estimates of popula-
tion differentiation (either FST or branch length) are highly uncertain,
which might lead to false discoveries of selection signature (Holsinger
and Weir, 2009; Weir et al., 2005). Recent studies (Elhaik, 2012;
Maruki et al., 2012) and our results (not shown) suggested the empiri-
cal distribution of population differentiation estimates are substantially
inﬂuenced by allele frequency. Therefore, we selected “null” SNPs with
matched ancestral allele frequency to the tested GWA SNPs on a one-
by-one basis in obtaining the empirical p-values.
Third, we implicitly assumed the reported GWA SNPs were the real
functional variants. It is always possible that a reported SNP is simply
in close LD (high r2 and hence similar allele frequency) with the real
functional variant in the discovery samples but not in other populations.
Such different LD patterns between populations would likely lead to in-
accurate estimates of population differentiation andhence the signature
of natural selection. Allelic heterogeneity at the complex trait associated
loci (Lango Allen et al., 2010; Zhang et al., 2012)may further complicate
detection and interpretation of natural selection signals.
Lastly, we used a purely empirical method to access the statistical
signiﬁcance of identiﬁed signatures of natural selection. This approach
does not require assumptions about population demography and sim-
ply considers “outliers” as likely targets of natural selection (Akey
et al., 2002). Simulation study suggested that such methods have a
high false-negative rate and tends to provide a biased view of selection,
depending on the mode of selection and demographic history (Nielsen
et al., 2007; Teshima et al., 2006). In addition, we did not rigidly account
formultiple testing in our study. Therefore, the “signiﬁcant” results from
our study should be interpreted as exploratory rather than statistically
conﬁrmatory evidence.
5. Conclusions
We present here a comprehensive empirical study of natural
selection on standing variants associatedwith complex human traits. Al-
though the knownGWA SNPs represent incomplete genetic architecture
of the complex traits and our methods might suffer from some technical
limitations, our results revealed some general features of natural selec-
tion on complex traits associated variants. First, natural selection on
standing variants associatedwith complex traits is a common phenome-
non, although the strength of selection is usuallyweak and hard to be ro-
bustly detected for individual variants. Second, the signatures of
selection of a particular trait usually enriched in speciﬁc human lineages
indicating recent adaption of different complex traits might be associat-
ed with temporarily and geographically speciﬁc environmental chal-
lenges. Third, as indicated by the strong correlation between the effect
sizes and the estimated strength of selection, some traits (e.g. height or
urate level) might have strong ﬁtness effect and might be the “focal”
polygenic adaptive traits, through which selection drives the changes
in allele frequencies. But for those traits without clear correlation be-
tween the effect sizes and the strength of selection, the selection on the
trait associated variantsmight act through other correlated traits. Fourth,
the genetic response (i.e. changes in allele frequencies) to natural selec-
tion of complex traits could be highly stochastic. That is, polygenic adap-
tation can accelerate differentiation between populations but generally
does not produce predictable directional changes in allele frequencies.
Fifth, the evolutionary scenario of a single complex trait could be very
heterogeneous and multiple mechanisms (i.e. pleiotropy, hitchhiking,
epistasis, etc) may act together on different variants.
Taken together, natural selection on standing variants of complex
traits is a common and complex phenomenon governed by a wide
range of evolutionary factors, but none with clear dominant and deter-
ministic effect. To pinpoint the genetic changes in responding a particu-
lar environmental challenge and the identiﬁcation of underlie adaptive
traits will be a challenging task even with large genomic data sets.Acknowledgments
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